Could centrifugal bioreactor accelerate cell-therapy manufacturing?
European Pharmaceutical Review
NOVEMBER 1, 2023
Washington State University researchers have developed a centrifugal bioreactor that is able to manufacture T cells, at 95 percent of the maximum growth rate — about 30 percent quicker than current technologies. Kaiphanliam and co-author Brenden Fraser-Hevlin have also started a company, Ananta Technologies Inc.,
Let's personalize your content